Siste forsøk

EudraCT Number: 2020-005019-29

Sponsor Protocol Number: Rux-cALL-Pol_2020

Start Date:

Sponsor Name: Medical University of Lodz

Full Title: Single-arm interventional study with ruxolitinib and AIOEP-BFM2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway.

Medical condition: Acute Lymphoblastic Leukemia with confirmed activating of JAK/STAT pathway in children and adolescents

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	100000004864	10000845	Acute lymphoblastic leukemia	LLT
	22.0	100000004850	10072213	JAK-2 mutation	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2007-000730-40

Sponsor Protocol Number: SOCRATES

Start Date:

Sponsor Name: Heinrich-Heine-Universität Düsseldorf

Full Title: Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC)

Medical condition: histologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCC

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10019828	Hepatocellular carcinoma non-resectable	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2009-011148-21

Sponsor Protocol Number: D0520C00012

Start Date:

Sponsor Name: AstraZeneca AB

Full Title: A 12-week, randomised, double-blind, placebo-controlled, parallel group, multinational, phase IIb dose range finding study to evaluate the efficacy and safety of AZD9668 administered orally at 3 do...

Medical condition: Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) SK (Completed)

Trial results: View results

EudraCT Number: 2004-001316-31

Sponsor Protocol Number: E01/04/SLIT1-M

Start Date:

Sponsor Name: ALK-ABELLO, S.A.

Full Title: TOLERABILIDAD DE LAS VACUNAS ALERGÉNICAS VALORADAS EN UNIDADES DE MASA Y ADMINISTRADAS POR VÍA SUBLINGUAL. ESTUDIO RANDOMIZADO DOBLE CIEGO CONTROLADO CON PLACEBO EN PACIENTES CON ENFERMEDAD ALÉRGIC...

Medical condition: Rinitis o rinoconjuntivitis alérgica perenne (ácaros) o estacional (gramíneas) con/sin síntomas de asma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: View results

EudraCT Number: 2009-011911-19

Sponsor Protocol Number: QUE/09

Start Date:

Sponsor Name: Ludwig-Maximilian-University of Munich, Department of Psychiatry

Full Title: Impact of quetiapine prolong and escitalopram on the hypothalamic-pituitary-adrenocortical (HPA)-axis activity in depressed patients

Medical condition: In this study, patients suffering from unipolar depression are investigated. 40 unipolar depressed inpatients (age 18-65) enter the study after the procedure has been fully explained and written in...

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10012378	Depression	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-000761-16

Sponsor Protocol Number: ALXN1210-TMA-314

Start Date:

Sponsor Name: Alexion Pharmaceuticals, Inc.

Full Title: A Phase 3, Open-label, Single Arm, Multicenter Study of Ravulizumab in Addition to Best Supportive Care in Pediatric Participants (from 1 month to

Medical condition: hematopoietic stem cell transplant-associated thrombotic microangiopathy

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10005329 - Blood and lymphatic system disorders	10043645	Thrombotic microangiopathy	PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) FR (Ongoing) DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-004194-51

Sponsor Protocol Number: 020520

Start Date:

Sponsor Name: Medical University of Lodz

Full Title: A prospective, randomized, phase III open-label clinical trial with blinded end-point assessment to evaluate the efficacy and safety of cyclosporine and methotrexate in children and adolescent subj...

Medical condition: Atopic dermatitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-005092-13

Sponsor Protocol Number: MO42623

Start Date:

Sponsor Name: F. Hoffmann-La Roche Ltd

Full Title: A MULTICENTER, OPEN-LABEL PHASE IV STUDY TO EVALUATE OVERALL HEALTH, PHYSICAL ACTIVITY, AND JOINT OUTCOMES, IN PARTICIPANTS AGED ≥ 13 AND

Medical condition: Severe or Moderate Hemophilia A

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004850	10053753	Hemophilia A without inhibitors	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: IE (Prematurely Ended) DE (Ongoing) ES (Ongoing) IT (Ongoing) HU (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-021802-39

Sponsor Protocol Number: DB2113374

Start Date:

Sponsor Name: GlaxoSmithKline Research & Development Ltd

Full Title: A multicenter trial comparing the efficacy and safety of GSK573719/GW642444 with GSK573719 with tiotropium over 24 weeks in subjects with COPD

Medical condition: Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10038738 - Respiratory, thoracic and mediastinal disorders	10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2018-001931-27

Sponsor Protocol Number: STARS-trial

Start Date:

Sponsor Name: IRCCS Istituto Giannina Gaslini

Full Title: Comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS

Medical condition: Juvenile idiopathic arthritis (JIA) is an umbrella term that encompasses a heterogeneous group of disorders characterised by prolonged synovial inflammation that may cause destructive damage to joi...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004859	10059177	Juvenile arthritis	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

Siste forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner